ATYR — ATYR PHARMA INC

Ownership history in US BANCORP \DE\  ·  1 quarter on record

This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in ATYR PHARMA INC (ATYR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 316 — — 0.00% $228 $0.72
% of Fund (quarterly)    ATYR price (monthly, adj. close)

Other funds also holding ATYR

As of 2025 Q4 — sorted by position size

Rosalind Advisors, Inc. 4.78% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.18% Tikvah Management LLC 3Y 7Y 0.1% FEDERATED HERMES, INC. 3Y 7Y 0.01% Dauntless Investment Group, LLC 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% ADAR1 Capital Management, LLC 0.0% Virtu Financial LLC 3Y 7Y 0.0% KINGSWOOD WEALTH ADVISORS, LLC 0.0% XTX Topco Ltd 3Y 0.0%
← Back to US BANCORP \DE\ Holdings